Transamerica Financial Advisors, Inc. Biogen Inc. Transaction History

Transamerica Financial Advisors, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $256 - $292	1 New	1 $1,000
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $187 - $223	1 New	1 $0
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $1,554 - $2,488	-6 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $485 - $569	2 Added 50.0%	6 $2,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $236 - $355	-1 Reduced 20.0%	4 $1,000
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $277,478 - $320,384	-1,048 Reduced 99.53%	5 $2,000
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $271,334 - $359,334	1,049 Added 26225.0%	1,053 $282,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $268 - $341	-1 Reduced 20.0%	4 $2,000
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $179,170 - $200,957	-824 Reduced 99.4%	5 $2,000
Q2 2019 Aug 21, 2019	BUY	$219.29 - $241.72 $181,133 - $199,660	826 Added 27533.33%	829 $194,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $172,501 - $269,812	-796 Reduced 99.62%	3 $1,000
Q4 2018 Feb 04, 2019	SELL	$278.5 - $352.75 $68,789 - $87,129	-247 Reduced 23.61%	799 $241,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $17,610 - $23,029	-60 Reduced 5.42%	1,046 $370,000
Q2 2018 Jul 25, 2018	SELL	$257.52 - $306.91 $2.36 Million - $2.81 Million	-9,166 Reduced 89.23%	1,106 $321,000
Q1 2018 May 09, 2018	BUY	$260.13 - $367.91 $127,463 - $180,275	490 Added 5.01%	10,272 $2.81 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $3.01 Million - $3.37 Million	9,778 Added 244450.0%	9,782 $3.12 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $1,124 - $1,318	4	4 $2,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Transamerica Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Transamerica Financial Advisors, Inc. with notifications on news.